跳到正文
openFDA 已分级药品召回执法报告·· 12 天前AI 评分55

FDA 召回执法报告 D-0157-2027:AvKARE 醋酸氟氢可的松片批号 48353 因杂质/降解指标不合格被列为 II 类召回

FDA drug enforcement D-0157-2027: AvKARE — Failed Impurities/Degradation Specifications

AI 导读

FDA 召回执法报告记录 AvKARE 自愿召回醋酸氟氢可的松片 0.1mg(批号 48353),原因为杂质/降解指标不合格,分级为 II 类。召回于 2026-10-09 启动,分销范围覆盖美国全国,数量 8866 箱,状态为持续进行。报告日期为 2026-11-11,记录说明该日期不等同召回启动日期。

正文 · 原文

FDA drug recall enforcement report — D-0157-2027

Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "615 N 1st St",

"address_2": "",

"center_classification_date": "20261030",

"city": "Pulaski",

"classification": "Class II",

"code_info": "Lot # 48353; Exp. 10/31/2026",

"country": "United States",

"distribution_pattern": "U.S. Nationwide",

"event_id": "100126",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"ANDA040431"

],

"brand_name": [

"FLUDROCORTISONE ACETATE"

],

"generic_name": [

"FLUDROCORTISONE ACETATE"

],

"manufacturer_name": [

"AvPAK"

],

"original_packager_product_ndc": [

"0115-7033"

],

"package_ndc": [

"50268-330-11",

"50268-330-15"

],

"product_ndc": [

"50268-330"

],

"product_type": [

"HUMAN PRESCRIPTION DRUG"

],

"route": [

"ORAL"

],

"rxcui": [

"313979"

],

"spl_id": [

"47e530bb-3b7a-dae5-e063-6394a90a1149"

],

"spl_set_id": [

"2cd3965d-cab9-a97c-db61-7d03ced154f3"

],

"substance_name": [

"FLUDROCORTISONE ACETATE"

],

"unii": [

"V47IF0PVH4"

]

},

"postal_code": "38478-2403",

"product_description": "Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK, Manufactured for: AvKARE, Pulaski, TN 38748, NDC 50268-330-15",

"product_quantity": "8866 cartons",

"product_type": "Drugs",

"reason_for_recall": "Failed Impurities/Degradation Specifications",

"recall_initiation_date": "20261009",

"recall_number": "D-0157-2027",

"recalling_firm": "AvKARE",

"report_date": "20261111",

"state": "TN",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov